Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$94.8K Sell
391
-1,748
-82% -$473K 0.42% 53
2025
Q4
$646K Sell
2,139
-129
-6% -$38.6K 0.17% 59
2025
Q3
$640K Buy
2,268
+292
+15% +$76.4K 0.17% 63
2025
Q2
$582K Buy
1,976
+127
+7% +$32.7K 0.17% 70
2025
Q1
$460K Sell
1,849
-276
-13% -$67.5K 0.16% 72
2024
Q4
$467K Sell
2,125
-545
-20% -$121K 0.16% 68
2024
Q3
$590K Buy
2,670
+1,372
+106% +$269K 0.21% 67
2024
Q2
$224K Buy
+1,298
New +$226K 0.09% 107
2024
Q1
Sell
-1,450
Closed -$237K 151
2023
Q4
$237K Sell
1,450
-171
-11% -$25.8K 0.1% 129
2023
Q3
$227K Buy
+1,621
New +$231K 0.11% 129

Other funds holding IBM

Strategic Advocates's IBM Position: Q1 2026 in Review

Strategic Advocates reduced its IBM (IBM) stake by 82% in Q1 2026, selling an estimated $473K and leaving 391 shares worth $94.8K. The position accounts for 0.42% of the portfolio, ranked #53.

Strategic Advocates first reported a position in IBM in Q3 2023 and has held it in 10 quarters since. The position peaked at $646K in Q4 2025. 3,463 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • Strategic Advocates held 391 shares of IBM worth $94.8K as of Q1 2026.
  • Strategic Advocates sold 1,748 IBM shares in Q1 2026, an estimated $473K.
  • IBM made up 0.42% of Strategic Advocates's portfolio in Q1 2026, its #53 holding.
  • Strategic Advocates first reported a position in IBM in Q3 2023 and has held it in 10 quarters since.
  • Strategic Advocates's IBM position peaked at $646K in Q4 2025.
  • 3,463 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.